STAT3 and cancer: STAT3 signaling mediates the maintenance of CSCs by IL-6 in various cancer types118, and deacetylation of the STAT3 Lys685 residue by HDAC3 facilitates the phosphorylation of the Tyr705 residue to activate STAT3119.